IMAP France advises Biogroup on its acquisition of Oriade-Noviale group
Biogroup continued its development in France thanks to its merger with Oriade-Noviale/GLBM, a major player in medical biology in the Auvergne-Rhône-Alpes region.
Oriade-Noviale/GLBM, a group owned by its biologists, is positioned as a major player in medical biology in the Auvergne-Rhône-Alpes region. Operating 55 laboratories as well as 4 technical platforms, mainly in the departments of Isère, Loire and Haute-Savoie, Oriade-Noviale/GLBM achieved a turnover of approximately €100 million in 2019.
We love to hear from you. Our team is always here to chat.
Contact form
Thank you for your interest in IMAP. Please use the form below to tell us more about your current situation and we’ll be sure to have the right professional get back to you as soon as possible.
